BOULDER, Colo., Nov. 15, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare Conference in New York City. The public is welcome to participate in the conference through a webcast on the Array BioPharma website.(Logo: http://photos.prnewswire.com/prnh/20121029/LA02195LOGO) Event:Piper Jaffray Annual Health Care ConferencePresenter:Ron Squarer, Chief Executive OfficerDate:Tuesday, November 27, 2012Time:11:30 a.m. Eastern Time Location:The New York Palace, NYWebcast:www.arraybiopharma.comAbout Array BioPharmaArray BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small‑molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company, with two wholly‑owned programs, ARRY-614 and ARRY-520, and three partnered programs, selumetinib (with AstraZeneca), MEK162 (with Novartis), and danoprevir (with InterMune / Roche), having the potential to begin Phase 3 or pivotal trials by the end of calendar year 2013. For more information on Array, please go to www.arraybiopharma.com.
Tricia HaugetoArray BioPharma Inc.email@example.com
|SOURCE Array BioPharma Inc.|
Copyright©2012 PR Newswire.
All rights reserved